Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 0.8275 USD -7.75% Market Closed
Market Cap: 7.8m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Net Margin
Trinity Biotech PLC

-34.4%
Current
-38%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-34.4%
=
Net Income
-20.3m
/
Revenue
59.1m

Net Margin Across Competitors

Country IE
Market Cap 7.8m USD
Net Margin
-34%
Country US
Market Cap 199B USD
Net Margin
14%
Country US
Market Cap 191.3B USD
Net Margin
29%
Country US
Market Cap 141.3B USD
Net Margin
16%
Country US
Market Cap 134.2B USD
Net Margin
11%
Country IE
Market Cap 104.6B USD
Net Margin
13%
Country US
Market Cap 65.6B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.5B USD
Net Margin
74%
Country CN
Market Cap 307.8B CNY
Net Margin
33%
Country US
Market Cap 36.3B USD
Net Margin
9%
No Stocks Found

Trinity Biotech PLC
Glance View

Market Cap
7.8m USD
Industry
Health Care

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

TRIB Intrinsic Value
8.1873 USD
Undervaluation 90%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-34.4%
=
Net Income
-20.3m
/
Revenue
59.1m
What is the Net Margin of Trinity Biotech PLC?

Based on Trinity Biotech PLC's most recent financial statements, the company has Net Margin of -34.4%.